Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Infinity Pharmaceuti (INFI)

Infinity Pharmaceuti (INFI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Infinity Pharmaceuticals (INFI) Reports Q2 Loss, Tops Revenue Estimates

Infinity (INFI) delivered earnings and revenue surprises of 20.00% and 80.00%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

INFI : 0.9950 (-1.49%)
Infinity: 2Q Earnings Snapshot

CAMBRIDGE, Mass. (AP) _ Infinity Pharmaceuticals Inc. (INFI) on Thursday reported a loss of $9.5 million in its second quarter.

INFI : 0.9950 (-1.49%)
Infinity Pharmaceuticals Provides Company Update and Second Quarter 2020 Financial Results

--- Encouraging Early Clinical Activity in MARIO-3 Front-Line Triple Negative Breast Cancer Cohort to be Presented by Year End -

INFI : 0.9950 (-1.49%)
Infinity Announces the Date of Its Second Quarter Financial Results Conference Call and Webcast

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will host a conference call on July 30, 2020 at 4:30 p.m. ET to review its second quarter 2020 financial results and provide an update on the company.

INFI : 0.9950 (-1.49%)
Thinking about buying stock in Infinity Pharmaceuticals, Qudian Inc, Myomo Inc, Plug Power, or Sunrun Inc?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for INFI, QD, MYO, PLUG, and RUN.

INFI : 0.9950 (-1.49%)
MYO : 3.95 (+2.60%)
RUN : 43.25 (-0.67%)
Infinity (INFI) Up 4% Since Last Earnings Report: Can It Continue?

Infinity (INFI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

INFI : 0.9950 (-1.49%)
Infinity (INFI) Looks Good: Stock Adds 5.3% in Session

Infinity (INFI) saw a big move last session, as its shares jumped nearly 5% on the day, amid huge volumes.

INFI : 0.9950 (-1.49%)
ATXI : 10.40 (+0.48%)
Infinity Pharmaceuticals to Host a Virtual-Only 2020 Annual Meeting of Stockholders

--- To participate in the virtual meeting, stockholders must register by 11:59 ET on June 15, 2020 -

INFI : 0.9950 (-1.49%)
Infinity (INFI) Q1 Earnings Lag Estimates, IPI-549 in Focus

Infinity (INFI) posts a wider-than-expected loss for the first quarter of 2020.

RHHBY : 43.6200 (-0.48%)
BMY : 59.53 (+0.10%)
INFI : 0.9950 (-1.49%)
RCUS : 21.44 (+2.14%)
Infinity Pharmaceuticals (INFI) Reports Q1 Loss, Tops Revenue Estimates

Infinity (INFI) delivered earnings and revenue surprises of -111.11% and 74.69%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

INFI : 0.9950 (-1.49%)
Infinity: 1Q Earnings Snapshot

CAMBRIDGE, Mass. (AP) _ Infinity Pharmaceuticals Inc. (INFI) on Monday reported a loss of $10.9 million in its first quarter.

INFI : 0.9950 (-1.49%)
Infinity Pharmaceuticals Provides Company Update and First Quarter 2020 Financial Results

--- Infinity Voluntarily Pausing Enrollment on MARIO-275 to Evaluate the Risk/Benefit for Patients -

INFI : 0.9950 (-1.49%)
NTGN : 3.07 (+8.10%)
Radius' (RDUS) Q1 Earnings Miss Estimates, Sales Surpass

Radius (RDUS) reports wider-than-expected loss but beats sales estimates in the first quarter. The company lowers guidance for 2020.

LLY : 153.96 (-0.57%)
AMGN : 241.68 (-0.78%)
INFI : 0.9950 (-1.49%)
RDUS : 12.02 (-1.07%)
Endo (ENDP) Q1 Earnings Beat on Coronavirus-Led Stockpiling

Endo's (ENDP) earnings and sales beat estimates in the first quarter owing to increased customer inventory purchasing due to the COVID-19 pandemic

ENDP : 3.49 (-0.29%)
INFI : 0.9950 (-1.49%)
MNK : 1.4600 (-9.88%)
BHC : 19.23 (+1.26%)
Infinity Announces the Date of Its First Quarter Financial Results Conference Call and Webcast

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will host a conference call on Monday, May 11, 2020 at 4:30 p.m. ET to review its first quarter 2020 financial results and provide an update on the company....

INFI : 0.9950 (-1.49%)
Infinity (INFI) Upgraded to Buy: What Does It Mean for the Stock?

Infinity (INFI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

INFI : 0.9950 (-1.49%)
Apoptosis Market 2020 Comprehensive Analysis and Forecast to 2026

The latest market study provides a lucid understanding of the Apoptosis sector and the report scrutinizes the data by using primary and secondary research techniques. Moreover, it also sheds light on various...

INFI : 0.9950 (-1.49%)
NVS : 83.64 (-0.61%)
Infinity Pharmaceuticals Provides Update in Response to COVID-19 Pandemic

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today provided an update in response to the COVID-19 pandemic. The company has taken steps to ensure the safety of its patients and employees as well as the...

INFI : 0.9950 (-1.49%)
Infinity (INFI) Down 28.2% Since Last Earnings Report: Can It Rebound?

Infinity (INFI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

INFI : 0.9950 (-1.49%)
Infinity's IPI-549 Gets Fast Track Tag for Urothelial Cancer

The FDA bestows a Fast Track designation on Infinity's (INFI) IPI-549 in combination with Opdivo for treating advanced urothelial cancer. Stock rise.

RHHBY : 43.6200 (-0.48%)
BMY : 59.53 (+0.10%)
INFI : 0.9950 (-1.49%)
RCUS : 21.44 (+2.14%)

Van Meerten Stock Picks

The 5 Best Large Caps
Today I wanted to find the 5 best Large Caps per my screening criteria.
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar